That's true, and such companies are as rare as hen's teeth. A quick scan of companies I invest in reveals that ARB and SNL remunerate KMP / Directors around the $1M per annum - also modest. And the one that really stands out is OCL, they have 5 KMP / Directors, with remunerartion coming in at about $840k.
Another favourable characteristic that XRF shares with OCL is conservative accounting treatment of R&D. (Although in XRF's case the amount spent on R&D is quite low, yet most is amortised).
If XRF can follow in the footsteps of the aforementioned companies, I think we'll be more than content in the year's ahead.
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$1.96 |
Change
-0.050(2.49%) |
Mkt cap ! $276.1M | |||
| Open | High | Low | Value | Volume |
| $2.03 | $2.03 | $1.95 | $277.1K | 140.3K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 2787 | $1.96 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.97 | 1518 | 2 |
View Market Depth
| Last trade - 13.13pm 29/07/2025 (20 minute delay) ? |
| XRF (ASX) Chart |